Anthrax shipments came from military site in Utah desert - KCTV5

SALT LAKE CITY (AP) - The U.S. Army's mistaken shipment of live anthrax samples to government and commercial laboratories occurred at a military post in a desolate stretch of the Utah desert that has been testing chemical weapons since it opened in 1942.

Read more: http://www.kctv5.com/story/29186553/anthrax-shipments-came-from-military-site-in-utah-desert#ixzz3bWPblpUi



Anthrax shipments came from military site in Utah desert - KCTV5

Pentagon: Military mistakenly shipped live anthrax samples - KCTV5

WASHINGTON (AP) - The Centers for Disease Control and Prevention said Wednesday it is investigating what the Pentagon called an inadvertent shipment of live anthrax spores to government and commercial laboratories in as many as nine states, as well as one overseas, that expected to receive dead spores.

Read more: http://www.kctv5.com/story/29170998/pentagon-military-mistakenly-shipped-live-anthrax-samples#ixzz3bRlWOJv3



Pentagon: Military mistakenly shipped live anthrax samples - KCTV5

Ahead of Print -Oligella ureolytica Bacteremia in Elderly Woman, United States - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Oligella ureolytica Bacteremia in Elderly Woman, United States - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Pseudogymnoascus destructans

From the USFWS Southwest Region:

More sad news came out today about the spread of the fungus that causes white-nose syndrome. Three tri-colored bats from a privately owned cave in eastern Oklahoma's Delaware County have tested positive for the fungus Pseudogymnoascus destructans. With these new findings, Oklahoma becomes the third state where the fungus has been confirmed, but the disease is not yet present. http://bit.ly/1Lirc3k

Photo credit: Pete Pattavina

Ahead of Print -The Past Is Never Dead—Measles Epidemic, Boston, Massachusetts, 1713 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -The Past Is Never Dead—Measles Epidemic, Boston, Massachusetts, 1713 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Asymptomatic Malaria and Other Infections in Children Adopted from Ethiopia, United States, 2006–2011 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

We screened 52 children adopted from Ethiopia for malaria because they had previously lived in a disease-endemic region or had past or current hepatomegaly or splenomegaly. Seven (13.5%) children had asymptomatic malaria parasitemia by microscopy (n = 2) or PCR (n = 5). Our findings suggest that adoptees at risk for asymptomatic malaria should be screened, preferably by PCR.



Ahead of Print -Asymptomatic Malaria and Other Infections in Children Adopted from Ethiopia, United States, 2006–2011 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Detection of Circovirus in Foxes with Meningoencephalitis, United Kingdom, 2009–2013 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

A fox circovirus was identified in serum samples from foxes with unexplained neurologic signs by using viral metagenomics. Fox circovirus nucleic acid was localized in histological lesions of the cerebrum by in situ hybridization. Viruses from the family Circoviridae may have neurologic tropism more commonly than previously anticipated.



Ahead of Print -Detection of Circovirus in Foxes with Meningoencephalitis, United Kingdom, 2009–2013 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Outbreak of Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to Vietnam, South Korea - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

We investigated an October 2014 outbreak of illness caused by Shigella sonnei in a daycare center in South Korea. The outbreak strain was resistant to extended-spectrum cephalosporins and fluoroquinolones and was traced to a child who had traveled to Vietnam. Improved hygiene and infection control practices are needed for prevention of shigellosis.



Ahead of Print -Outbreak of Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to Vietnam, South Korea - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Distinct Lineages of Bufavirus in Wild Shrews and Nonhuman Primates - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Viral metagenomic analysis identified a new parvovirus genome in the intestinal contents of wild shrews in Zambia. Related viruses were detected in spleen tissues from wild shrews and nonhuman primates. Phylogenetic analyses showed that these viruses are related to human bufaviruses, highlighting the presence and genetic diversity of bufaviruses in wildlife.



Ahead of Print -Distinct Lineages of Bufavirus in Wild Shrews and Nonhuman Primates - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Severe Pediatric Adenovirus 7 Disease in Singapore Linked to Recent Outbreaks across Asia - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

During November 2012–July 2013, a marked increase of adenovirus type 7 (Ad7) infections associated with severe disease was documented among pediatric patients in Singapore. Phylogenetic analysis revealed close genetic links with severe Ad7 outbreaks in China, Taiwan, and other parts of Asia.



Ahead of Print -Severe Pediatric Adenovirus 7 Disease in Singapore Linked to Recent Outbreaks across Asia - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Salmonella enterica Paratyphi A Infections in Travelers Returning from Cambodia, United States - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC

May 13, 2015



Ahead of Print -Salmonella enterica Paratyphi A Infections in Travelers Returning from Cambodia, United States - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC

GSK #News Release:

GSK and UNC-Chapel Hill announce novel partnership to accelerate search for HIV cure

10 May 2015

Unique public-private collaboration will create HIV Cure center and a new company to bring together academic and pharmaceutical research scientists

Issued: Research Triangle Park, NC

The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and healthcare company with a legacy of success in developing treatments for HIV, today announced the creation of a dedicated HIV Cure center and a jointly owned new company that will focus on discovering a cure for HIV/AIDS. This unique public-private partnership will redefine the traditional way of conducting research and create a new model to seek the breakthroughs needed to tackle an extraordinarily challenging global health issue.

The HIV Cure center will be located on the UNC-Chapel Hill campus and will focus exclusively on finding a cure for HIV/AIDS. The new company, Qura Therapeutics, will handle the business side of the partnership, including intellectual property, commercialization, manufacturing and governance. Together, the HIV Cure center and Qura Therapeutics will serve as a catalyst for additional partners and public funding that will likely be needed to eradicate HIV worldwide. The collaboration is also expected to recruit and attract top talent from around the world.

“The excitement of this public-private partnership lies in its vast potential,” said UNC-Chapel Hill Chancellor Carol L. Folt. “Carolina has been at the forefront of HIV/AIDS research for the last 30 years. This first of its kind, joint-ownership model is a novel approach toward finding a cure, and we hope it serves as an invitation to the world’s best researchers and scientists. Today, Carolina’s best are taking another major step in the global fight against HIV/AIDS.”

“Like UNC, GSK has a long legacy of HIV research success. From the development of the world’s first breakthrough medicine for HIV patients in the 1980s, to our leadership in the market today through ViiV Healthcare, we’re continuously challenging ourselves to meet the needs of patients,” GSK CEO Sir Andrew Witty said. “This partnership is a testament to our past and present leadership, innovation and commitment to this field. We are inspired by the confidence that with the right resources and research teams, we will be able to make a meaningful impact towards a cure for HIV.”

UNC-Chapel Hill and GSK will focus on the latest scientific approaches to curing HIV, including a leading research approach toward an HIV cure, sometimes called “shock and kill.” This approach seeks to reveal the hidden virus that persists in people with HIV infection despite successful drug therapy, and augment the patient’s immune system to clear these last traces of the virus and infected cells. Part of this new paradigm was first tested at UNC-Chapel Hill and in 2012 a team led by UNC-Chapel Hill researchers demonstrated that latent HIV might be unmasked by new therapies. Recently, researchers at the university received Food and Drug Administration approval for a study in HIV-positive volunteers to combine this technique and an immune-boosting strategy.

“After 30 years of developing treatments that successfully manage HIV/AIDS without finding a cure, we need both new research approaches to this difficult medical problem and durable alliances of many partners to sustain the effort that will be needed to reach this goal,” said Dr. David Margolis, Carolina professor of medicine and leader of the Collaboratory of AIDS Researchers for Eradication (CARE). “The ‘shock and kill’ approach has shown significant promise in early translational research on humans and has been the focus of research for the last several years.”

“Although today’s treatments for HIV mean that millions of lives have been saved, people still have to take a lifetime of treatments, which takes an emotional toll and places an economic burden on society that is particularly challenging in countries with limited resources,” said Zhi Hong, senior vice president and head of the Infectious Diseases Therapy Area Unit at GSK. “This is why we must dedicate the next 30 years to finding a cure and scaling it up so that one day we will end the HIV/AIDS epidemic.”

Through the new company, GSK will invest $4 million per year for five years to fund the initial HIV Cure center research plan, and a small research team from GSK will move to Chapel Hill to be co-located with UNC researchers. The University will provide world-class laboratory space on its medical campus for the HIV Cure center and the new company. GSK will be contributing its expertise and know-how in medicines discovery, development and manufacturing, and UNC-Chapel Hill will bring to the table its research and translational medicine capabilities, talent, as well as access to patients and funding.

GSK’s investment in the HIV Cure center is separate from its investment in the discovery of novel antiretroviral (ARV) therapies in support of ViiV Healthcare, a global specialist HIV company dedicated to delivering advances in treatment and care for people living with HIV and owned by GSK, Pfizer and Shionogi. GSK’s HIV Discovery Performance Unit will continue its work on new ARVs in the Research Triangle Park area of North Carolina. ViiV has significant clinical expertise and will play an advisory role to the HIV Cure center and Qura Therapeutics.

The announcement of the UNC-GSK collaboration will be made Monday, 11 May at 9:30amEDT and can be viewed live online at https://youtu.be/AE9MWKIUNbM.

GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information please visit www.gsk.com.

Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D 'Risk factors' in the company's Annual Report on
Form 20-F for 2014.
Registered in England & Wales:
No. 3888792

Registered Office:
980 Great West Road
Brentford, Middlesex
TW8 9GS

European Space Agency backs work mapping Scottish tick hotspots - BBC News

The European Space Agency (ESA) has given financial backing to a Scottish project aiming to use new technology to map tick hotspots and fight disease.



European Space Agency backs work mapping Scottish tick hotspots - BBC News

Ahead of Print -Swine Influenza A(H3N2) Virus Infection in Immunocompromised Man, Italy, 2014 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Because swine influenza virus infection is seldom diagnosed in humans, its frequency might be underestimated. We report a immunocompromised hematologic patient with swine influenza A(H3N2) virus in 2014 in Italy. Local pigs were the source of this human infection.



Ahead of Print -Swine Influenza A(H3N2) Virus Infection in Immunocompromised Man, Italy, 2014 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011–2013 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Plasmodium falciparum resistance to artemisinin derivatives is emerging in Asia. We examined molecular markers of resistance in 78 children in Uganda who had severe malaria and were treated with intravenous artesunate. We observed in the K13-propeller domain, A578S, a low-frequency (3/78), nonsynonymous, single-nucleotide polymorphism associated with prolonged parasite clearance.



Ahead of Print -Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011–2013 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Results from the National Legionella Outbreak Detection Program, the Netherlands, 2002–2012 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

In 2002, the National Legionella Outbreak Detection Program was implemented in the Netherlands to detect and eliminate potential sources of organisms that cause Legionnaires’ disease (LD). During 2002–2012, a total of 1,991 patients with LD were reported, and 1,484 source investigations were performed. Of those sources investigated, 24.7% were positive for Legionella spp. For 266 patients with LD, 105 cluster locations were identified. A genotype match was made between a strain detected in 41 patients and a strain from a source location. Despite the systematic approach used by the program, most sources of LD infections during 2002–2012 remained undiscovered. Explorative studies are needed to identify yet undiscovered reservoirs and transmission routes for Legionella bacteria, and improved laboratory techniques are needed to detect Legionella spp. in clinical samples from patients possibly exposed to microbial flora (e.g., in soil).



Ahead of Print -Results from the National Legionella Outbreak Detection Program, the Netherlands, 2002–2012 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Macacine Herpesvirus 1 in Long-Tailed Macaques, Malaysia, 2009–2011 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Macacine herpesvirus 1 (MaHV1; B virus) naturally infects macaques (Macaca spp.) and can cause fatal encephalitis in humans. In Peninsular Malaysia, wild macaques are abundant, and translocation is used to mitigate human–macaque conflict. Most adult macaques are infected with MaHV1, although the risk for transmission to persons who handle them during capture and translocation is unknown. We investigated MaHV1 shedding among 392 long-tailed macaques (M. fascicularis) after capture and translocation by the Department of Wildlife and National Parks in Peninsular Malaysia, during 2009–2011. For detection of MaHV1 DNA, PCR was performed on urogenital and oropharyngeal swab samples. Overall, 39% of macaques were shedding MaHV1 DNA; rates of DNA detection did not differ between sample types. This study demonstrates that MaHV1 was shed by a substantial proportion of macaques after capture and transport and suggests that persons handling macaques under these circumstances might be at risk for exposure to MaHV1.



Ahead of Print -Macacine Herpesvirus 1 in Long-Tailed Macaques, Malaysia, 2009–2011 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Genome of Emerging Norovirus GII.17, United States, 2014 - Volume 21, Number 8—August 2015 - Emerging Infectious Disease journal - CDC

To determine whether the norovirus strain GII.17 recently detected in Maryland, USA, (Hu/GII.17/Gaithersburg/2014/US) is spreading globally, we characterized the genome. High similarity with the norovirus GII.17 that caused recent outbreaks in Asia indicates that the same strain was present in the United States during the 2014–15 norovirus season (winter).



Ahead of Print -Genome of Emerging Norovirus GII.17, United States, 2014 - Volume 21, Number 8—August 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013–2014 - Volume 21, Number 8—August 2015 - Emerging Infectious Disease journal - CDC

We determined the presence of neutralizing antibodies to Middle East respiratory syndrome coronavirus in persons in Qatar with and without dromedary contact. Antibodies were only detected in those with contact, suggesting dromedary exposure as a risk factor for infection. Findings also showed evidence for substantial underestimation of the infection in populations at risk in Qatar.



Ahead of Print -Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013–2014 - Volume 21, Number 8—August 2015 - Emerging Infectious Disease journal - CDC

Blue Bell recall: Feds detail Listeria contamination and unsanitary conditions - May. 7, 2015

Government documents released Thursday show that a single Blue Bell Creameries plant in Oklahoma tested positive for Listeria 16 times since 2013.



Federal inspectors also detail a host of unsanitary conditions as recently as last month, the documents show.



Blue Bell recall: Feds detail Listeria contamination and unsanitary conditions - May. 7, 2015

Ahead of Print -Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005–2010 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC

Acquired resistance to antituberculosis drugs decreases effective treatment options and the likelihood of treatment success. We identified risk factors for acquisition of drug resistance during treatment for multidrug-resistant tuberculosis (MDR TB) and evaluated the effect on treatment outcomes. Data were collected prospectively from adults from Arkhangelsk Oblast, Russia, who had pulmonary MDR TB during 2005–2008. Acquisition of resistance to capreomycin and of extensively drug-resistant TB were more likely among patients who received <3 effective drugs than among patients who received >3 effective drugs (9.4% vs. 0% and 8.6% vs. 0.8%, respectively). Poor outcomes were more likely among patients with acquired capreomycin resistance (100% vs. 25.9%), acquired ofloxacin resistance (83.6% vs. 22.7%), or acquired extensive drug resistance (100% vs. 24.4%). To prevent acquired drug resistance and poor outcomes, baseline susceptibility to first- and second-line drugs should be determined quickly, and treatment should be adjusted to contain >3 effective drugs.



Ahead of Print -Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005–2010 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Etymologia: Quinine - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Etymologia: Quinine - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Treating a bacterial infection with bacteria lowers chances of recurrence | fox4kc.com

KANSAS CITY, Kan. — Many of us have never heard of a bad bacterial infection called C. diff. It strikes a half million Americans a year, killing close to 30,000. New research finds treating patients with a different strain of the same bacteria can lower the chances of recurrence.

C. diff is short for Clostridium difficile. It often attacks people in hospitals and nursing homes, but you can get C. diff anywhere. Think of it as the worst kind of guest — one that won’t leave. C. diff spores can sit on a faucet, a phone or remote control for months. The bacteria which come from feces are passed to the hands and then into our bodies, usually at mealtime. C. diff causes diarrhea, severe abdominal pain, loss of appetite and fever.

Treating a bacterial infection with bacteria lowers chances of recurrence | fox4kc.com

Ahead of Print -Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Data on prevalence of hepatitis E virus (HEV) in Malawi is limited. We tested blood samples from HIV-uninfected and -infected populations of women and men enrolled in research studies in Malawi during 1989–2008 to determine the seroprevalence of HEV, hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV). Samples were tested for IgG against HEV, total antibodies against HAV and HCV, and presence of HBV surface antigens. Of 800 samples tested, 16.5% were positive for HEV IgG, 99.6% were positive for HAV antibodies, 7.5% were positive for HBV surface antigen, and 7.1% were positive for HCV antibodies. No clear trends over time were observed in the seroprevalence of HEV, and HIV status was not associated with hepatitis seroprevalence. These preliminary data suggest that the seroprevalence of HEV is high in Malawi; the clinical effects may be unrecognized or routinely misclassified.



Ahead of Print -Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Light, Reflection, Illumination - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Light, Reflection, Illumination - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC

Deadly, contagious canine flu bears watching | Local News - KMBC Home

Virus not yet detected in KC metropolitan area

Deadly, contagious canine flu bears watching | Local News - KMBC Home

Ahead of Print -Seropositivity for Avian Influenza H6 Virus among Humans, China - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Seropositivity for Avian Influenza H6 Virus among Humans, China - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Pulmonary Complications of HIV - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Pulmonary Complications of HIV - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Characterization of 3 Megabase-Sized Circular Replicons from Vibrio cholerae - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Characterization of 3 Megabase-Sized Circular Replicons from Vibrio cholerae - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -The Emergence of Tropical Medicine in France - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -The Emergence of Tropical Medicine in France - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Wildlife Reservoir for Hepatitis E Virus, Southwestern France - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Pigs are a reservoir for hepatitis E virus (HEV). To determine the relative contribution of game to the risk for human HEV infection in southwestern France, we tested wildlife samples. HEV RNA was in 3.3% of wildlife livers, indicating that in this region, eating game meat is as risky as eating pork.



Ahead of Print -Wildlife Reservoir for Hepatitis E Virus, Southwestern France - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Novel Arenavirus Isolates from Namaqua Rock Mice, Namibia, Southern Africa - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Arenaviruses are feared as agents that cause viral hemorrhagic fevers. We report the identification, isolation, and genetic characterization of 2 novel arenaviruses from Namaqua rock mice in Namibia. These findings extend knowledge of the distribution and diversity of arenaviruses in Africa.



Ahead of Print -Novel Arenavirus Isolates from Namaqua Rock Mice, Namibia, Southern Africa - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Geographic Range Expansion for Rat Lungworm in North America - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Using quantitative PCR analysis and DNA sequencing, we provide evidence for the presence of rat lungworm (Angiostrongylus cantonensis) in Oklahoma, USA, and identified a potentially novel rat host (Sigmodon hispidus). Our results indicate a geographic range expansion for this medically and ecologically relevant parasite in North America.



Ahead of Print -Geographic Range Expansion for Rat Lungworm in North America - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Diversity of Bartonella spp. in Bats, Southern Vietnam - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC

Ahead of Print -Diversity of Bartonella spp. in Bats, Southern Vietnam - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC